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SUMMARY 
Background: The Thinking Healthy Programme (THP), endorsed by WHO, is an evidence-based 
intervention for perinatal depression. We adapted THP for delivery by volunteer peers (THPP) – lay 
women from the community – and assessed its effectiveness and cost-effectiveness in Rawalpindi, 
Pakistan. 
Methods: In this cluster randomised controlled trial, 40 village-clusters were equally randomised to 
intervention (THPP plus Enhanced Usual Care (EUC)) or to EUC-alone. Consenting pregnant women 
aged ≥18 years who scored >10 on the nine-item Patient Health Questionnaire (PHQ-9) were eligible. 
Follow-up visits were at 3 and 6 months post childbirth. Primary outcomes were depressive symptoms 
score and remission at 6 months post-childbirth. Secondary outcomes included recovery from 
depression, levels of disability and perceived social support and child outcomes. All assessors were 
masked, and analyses were modified intention-to-treat. The trial was registered with ClinicalTrials.gov 
(NCT02111915). 
Findings: Of the 570 women enrolled between 15th October 2014 and 25th February 2016, 227/283 
(80%) and 226/287 (79%) women in the THPP plus EUC and EUC-alone groups, respectively, 
contributed primary outcome data. Compared to women in the EUC-alone group, those in the THPP 
plus EUC group at 6 months had lower PHQ-9 scores and better proportions of remission, but neither 
reached statistical significance (standardised mean difference, SMD=-0·13, 95% CI -0·31 to 0·06, 
p=0·07; 49% vs 45%; Prevalence Ratio PR=1·12, 95% CI 0·95 to 1·29, p=0.14 respectively). Repeated 
measures analyses over the 6 months post childbirth showed beneficial intervention effects on both 
PHQ-9 scores (SMD=-0·22, 95%CI -0·35 to -0·09, p=<0·001) and remission (PR=1·15 95% CI 1·02 to 
1·28, p=0·02), disability scores (SMD=-0·12, 95% CI -0·25 to 0·01, p=0·03) and perceived social support 
scores (SMD=0·16, 95%CI 0·03 to 0·29, p=0·01). THPP was associated with slightly higher costs than 
EUC-alone but significantly better outcome, thereby rendering it a cost-effective intervention; total 
societal cost per unit improvement on PHQ-9 was US$ 2·65 (95% CI 1·82 to 3·49) at 3 months post 
childbirth, US$ 1·17 (95% CI -0·53 to 2·88) for the 3-6-month post-childbirth period and US$ 15·50 
(95% CI 9·59 to 21·61) over the study period as a whole. There was no evidence of differences in 
serious adverse events by group. 
Interpretation: THPP showed moderate effects on symptom severity and remission from perinatal 
depression over the 6-month postnatal period among women caring for infants and was also cost-
effective. Our intervention delivered by lay peers can be a potential step towards using an untapped 
human resource to address the treatment gap of perinatal depression.  
Funding: National Institute of Mental Health, USA, through 1U19MH095687  
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INTRODUCTION 
 
Perinatal depression, which occurs during pregnancy or within the first year postpartum, affects 
around 20-25% of women in low and middle-income countries (LMICs), including Pakistan.1-3 
Perinatal depression is an important public health problem as it is associated with disability and 
suicide in women, and adverse child outcomes including impaired physical health1,4 and poor 
cognitive and socioemotional development.5 In most low resource settings, perinatal depression is 
largely undiagnosed and untreated due to human resource constraints and ill-equipped health 
systems, with up to 90% of those in need untreated.6  
 
The Thinking Healthy Programme (THP) for perinatal depression is an evidence-based intervention 
based on principles of cognitive behavior therapy. It includes strategies incorporating behavioural 
activation, active listening, collaboration with the family, guided discovery and homework.7 THP 
was designed to be delivered by community health workers, and found to be effective in a large 
community-based randomised controlled trial (RCT) in Pakistan8, where it more than halved the 
prevalence of perinatal depression and significantly improved child health outcomes like diarrheal 
episodes and vaccination coverage.8 It is the first low-intensity psychological intervention to be 
adopted by the WHO.9  
 
Despite these promising results, efforts at scale-up of THP are limited by competing demands on 
community health workers’ time, as programme priorities remain communicable diseases, 
nutrition and child survival.10-12 The treatment gap for perinatal depression remains high for most 
LMICs and is likely to remain so, given the scarcity of human resource and funds allocated for 
mental health.   
 
To address this barrier to scale-up, we adapted the THP for delivery by peers, i.e. lay women from 
the community with no prior health training or experience, but shared socio-demographic and life 
experiences with the target population.13 Our formative research indicated that such peers were 
feasible and acceptable delivery agents for the intervention and could provide us a potential 
human resource solution to address the treatment gap.14 The adapted Thinking Healthy 
Programme-Peer-delivered (THPP) was evaluated for effectiveness and cost-effectiveness 
compared to enhanced usual care (EUC) in two diverse rural and peri-urban contexts of South Asia 
(Pakistan and India).15  
 
In this paper, we describe the findings of THPP delivered in Pakistan by volunteer peers (called 
‘Razakaars’) in a rural underserved population. These peers worked in close collaboration with 
government Lady Health Workers (LHWs) and delivered the intervention through a mix of 
individual and group sessions. LHWs are government employed community health workers which 
have about 25 stipulated duties.10 She covers approximately 1500 population (200-250 households 
that are visited monthly). The duties largely entail MNCH preventive, promotive services, eg 
registering pregnant women, providing family planning services etc. The results of the India trial 
based in an urban population, where THPP was delivered through individual sessions, are reported 
in the companion paper.  
 
 
  
4 
 
METHODS 
Setting 
The trial was conducted in Kallar Syedan, a rural sub-district of Rawalpindi, Pakistan. It is a 
socioeconomically deprived area with poverty rates over 50%16, female literacy rates of 45% and high 
fertility rates (3.8 births per woman).17 The economy is largely agrarian, with a population consisting 
of close-knit communities living in villages and large household sizes (average 6·2 persons per 
household). Health care is provided by village-based LHWs, each responsible for a population of about 
1500 with a focus on maternal and child health, and a primary-care facility staffed by a physician, 
midwife and a paramedic serving a population of about 25,000. About a quarter of all women in rural 
Rawalpindi suffer from perinatal depression.8,18 
Study design and participants  
The trial was a single-blind stratified cluster RCT. The unit of randomisation was a village-cluster 
(population of 2400-3600 serviced by 2-3 LHWs). Eligible village-clusters were geographically separate 
to minimise contamination. 40 village-clusters were randomised equally to intervention (THPP Plus 
Enhanced Usual Care [EUC]) or control (EUC-alone) groups. 
Potentially eligible participants were women in their third trimester of pregnancy aged >18 years, 
registered with the local LHWs and intending to stay in the study area for at least one year. LHWs 
register all pregnant women in their catchment areas; we approached all the pregnant women on 
the lists of all the LHWs. About 95% of the women in the study area covered by LHWs. Participants 
who did not speak Urdu, Punjabi or Potohari, or who needed immediate medical or psychiatric 
inpatient care were not eligible. Potentially eligible participants were screened for depression with 
the Urdu version of the Patient Health Questionnaire 9 (PHQ-9)19 after written informed consent for 
screening (or witnessed informed consent for illiterate participants; for such women the 
questionnaires were read out aloud to them and responses marked by trained assessment teams). 
Women who screened positive (PHQ-9 score ≥10) were consented for baseline interview for 
enrolment. The PHQ-9 with a cut-off score of >10 has shown a positive predictive value of 5520 and 
has previously been used in India (Patel, 2017);  it has been validated in perinatal depression 
populations in Pakistan19 as well as in other LMIC such as in Ghana and shows acceptable criterion-
related validity and reliability for screening for depressive symptoms among women in the antenatal 
and postnatal period..   Ethical approval was obtained from the Institutional Review Boards (IRBs) at 
the University of Liverpool, the London School of Hygiene and Tropical Medicine (LSHTM), and the 
Human Development Research Foundation (the trial-implementing institution in Pakistan). The trial 
protocol has been published previously.21 
Randomisation and masking 
The randomisation list for village-clusters, stratified by 11 union councils, was prepared by an 
independent statistician using a computerised randomisation sequence. Outcome assessors were 
blind to allocation at both baseline and follow up assessments, had no interaction with the 
intervention team and resided outside the study area. Trial Steering Committee (TSC) members, 
except the data manager (AZ), remained blind to the allocation status until the data were unmasked 
after interpretation at a TSC meeting on 23 October 2017. 
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Procedures  
After enrolment, a baseline socio-demographic questionnaire was administered to participants to 
collect data on potential effect-moderators of treatment effects (age, patient expectations at 
enrolment, baseline chronicity and severity of depression).  
As there is non-existent usual care for perinatal depression in Pakistan, participants in the EUC-alone 
group received standard care from the LHWs. In addition, treatment was enhanced for participants in 
the EUC group in the following ways: (1) all participants were informed of their screening results; (2) 
LHWs who had registered these pregnant women were also informed; (3) all the doctors and midwives 
at the primary health care centres were given the adapted mental health Gap Action Programme 
(mhGAP) treatment guidelines for perinatal depression22 which included information on how to refer 
severe cases and patients with suicide risk to specialist mental health care; and (4) participants were 
provided with an information sheet including details on where to seek appropriate health care during 
pregnancy and beyond.  
Participants in the intervention group received THPP in addition to EUC. THPP was developed during 
a two-year formative research phase.13 The core psychological strategies included behavioural 
activation; narratives and pictures to gently challenge unhelpful thinking and behaviour, and 
encourage alternate helpful ones; and simple everyday language that both the peers and the mothers 
could relate to. Brief class-room training was supplemented with regular group and field- supervision 
by non-mental health specialists, who in turn were supervised by a specialist therapist (cascade model 
of training and supervision). THPP consisted of 10 individual and 4 group sessions, each lasting 
between 30-45 minutes, from the third trimester (antenatal) to the sixth month post-childbirth 
(postnatal). THPP was front loaded, with 10 of the 14 sessions delivered during pregnancy and in the 
first 3 months postnatal. This was done to ensure early reduction in maternal depressive symptoms in 
this critical phase of infant-care.  
The peers who delivered THPP were local volunteer married women, around 30-35 years of age who 
had good communication skills. All had children and possessed a similar educational and 
socioeconomic background as participants. They were referred to as Razakaars which roughly 
translates to “volunteer helpers” in the local language (Urdu). Additional criteria of peers are 
published elsewhere.14 Peers were identified through LHWs and community elders. Recruitment and 
placement of the peers within the community was done through the primary health care centres 
and they were introduced in the community through the LHWs. A total of 66 Razakaars (3 per 
village-cluster) were recruited and trained. The peers received no monetary remuneration for the 
work. Razakaars received group supervisions during the trial ensuring fidelity. Their competency was 
assessed by the trainers using a checklist based on ENACT.23 The competency was assessed 
immediately after training and six months post-training. Peers were categorized as competent (and 
given depressed cases) if they scored at least 70% on the competency checklist. Individual sessions 
were delivered by the Razakaars at the participant’s homes; while the group sessions at LHW’s 
health house or a nearby place convenient for participants. Each Razakaar was given a maximum of 
seven cases (staggered over the trial period) and asked to make the first contact within two to three 
days of enrolment. Treatment completion was defined as attending at least 10 out of the possible 14 
sessions (see in results competency scores and therapy completion findings).  
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Outcomes 
Primary outcomes were depressive symptoms severity (PHQ-9 score) and remission (PHQ9 <5) 
assessed at 6 months post-childbirth. Remission was originally defined as PHQ-9 score <10 in the 
published trial protocol15 however, this was amended to PHQ-9 score <5 as a more robust and clinically 
meaningful measure of remission20 after discussion with the TSC prior to finalisation of the analysis 
plan. We confirmed that we would have adequate power for this outcome in October 2016, using data 
from the 6 months outcome data pooled across the arms (from the India trial) prior to the end of 
outcome evaluation. Approval for this change was obtained from the Data Safety Monitoring Board 
(DSMB) of the National Institute of Mental Health (NIMH) and the IRBs before unblinding.  
Secondary outcomes were depressive symptoms score and remission at 3 months post-childbirth, 
recovery (proportion not depressed at both 3 and 6 months post-childbirth). Secondary outcomes at 
3 and 6 months also included disability scores based on the 12-item WHO Disability Assessment 
Schedule (WHO-DAS 2·0), using the item-response theory based complex scoring method24, number 
of days unable to work in the last month, perceived social support (Multidimensional Scale of 
Perceived Social Support, MSPSS score), exclusive breastfeeding (WHO definition, namely feeding 
breastmilk exclusively in the previous 24 hours), and infant anthropometry (weight- and height-for-
age z scores). 
To enable an economic evaluation to be undertaken, the Client Service Receipt Inventory (CSRI)25 was 
administered to trial participants, who reported their details, in order to collect information on their 
use of health services at 3 and 6 months post-childbirth (copy of CSRI can be available on request from 
the corresponding author). Detailed information was recorded on contacts with a range of providers 
including average duration and time to access services. Information was collected on any use or tests 
or investigations as well as medication. Unit costs were calculated for all items of services use data, 
including medicines, tests, cost of travel to and from the facilities by the participants, salaries and 
related costs of government care providers, and private consultation fees. Health system costs were 
derived from in-patient/out-patient costs, costs of laboratory tests/investigations, medications, and 
intervention delivery (training and supervision of Razaakars) costs (see note under Appendix J for 
details of the types of costs included in the intervention). Societal costs encompassed health system 
costs and time/productivity costs (these included travel costs of the participants and accompanying 
family members associated with accessing OPD or in-patient services as well as any days out of role 
and any lost wages) covering both trial participants and family members. A human capital approach 
was adopted, whereby days out of role collected via the CSRI were multiplied by the estimated wage 
or monetary value of time to give an estimate of lost production (see Appendix J, K and L for details). 
Costs were estimated in Pakistani Rupees for the year 2015 and converted to US dollars at the end-
year rate for that year (105 Rupees to US$ 1) (found at https://www.xe.com/). Cost estimates were 
computed for a) the 6-month period of service use covering the third trimester and the first 3 months 
post-childbirth; b) the 3-month period of service use since the 3-month post-childbirth assessment; 
and c) the total 9-month period of the trial covering the third trimester and the first 6 months post-
childbirth. 
Unit costs used in the analysis, together with their respective sources, are shown in Appendix M; cost 
data taken from earlier years was inflated to 2015 levels using the International Monetary Fund 
consumer price index. We collected information on serious adverse events (SAEs; death of the 
participant due to any cause, loss of child, suicide attempt, hospitalisation, victimisation, infant 
abuse/neglect and stigmatisation, reported violence towards others). Apart from these, we collected 
social-demographic information at baseline.  
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Statistical analysis  
The sample size estimations for the 6-month primary outcomes assumed an intra-cluster correlation 
of 0·07 in the intervention group and 0·05 in the control group, and loss to follow up of 20%. Our 
target sample size was 560 participants (third trimester of pregnancy to 6 moths post-childbirth)  to 
provide 90% power to detect a difference for the primary outcome of remission of 65% in the THPP 
plus EUC group compared to 45% in the EUC-alone group; and 90% power to detect a standardised 
mean difference (SMD or effect size) of 0·4 for the primary outcome of PHQ-9 score. The original 
sample size calculations were based on remission (defined as PHQ-9 <10) in the THP trial in Pakistan8 
and conditional power was estimated based on blinded preliminary data from 134 participants in the 
companion India trial (prevalence of 67% across the two groups), and for symptom severity on the 
THP trial8 (using the THP Hamilton Depression Rating Scale at 6 months: THP group mean 4·5, standard 
deviation 6·0; control group mean 8·7, standard deviation 7·4). We assumed a more conservative 
effect size to allow for the possibility of contamination between arms and a diluted effect due to the 
delivery of the intervention by Razakaars.  
Outcomes were analysed on an intention-to-treat basis, among complete cases and modified to adjust 
for union council and baseline PHQ-9 score a priori, factors showing imbalance at baseline (chronicity 
of depression), and factors associated with missing 6-month outcome data (time between screening 
and childbirth; assessed on blinded data). For continuous outcomes, we used linear regression models, 
with results reported as standardised mean differences (SMD) calculated as the adjusted mean 
difference between the groups divided by the adjusted within-cluster standard deviation.26 To account 
for the village-clustering, we used generalised estimating equations with an exchangeable correlation 
structure using the “xtlogit, pa” command with robust standard errors. For categorical outcomes, we 
used logistic regression models, with results reported as prevalence ratios (PR), estimated from 
models with the following reference categories: union council (largest), moderate PHQ-9 (score 10-
14), mean time between screening and birth (3·0 months), and chronicity ≥12 weeks, using marginal 
standardisation with the delta method for the confidence intervals (CI)27. Sensitivity analyses for 
primary outcomes included random effects models, accounting for missing outcome data using 
multiple imputation (assuming missing at random) and alternative models for PHQ-9 score (Poisson, 
with robust standard errors, and negative binomial). For the primary outcomes, we assessed effect-
moderation of the treatment effect with a priori-defined potential moderators (recognising that 
power is low). We conducted repeated measures analyses combining the data from 3 and 6 months 
(using village-cluster as the panel variable),28 using a normal distribution to obtain p-values as the 
number of clusters was sufficiently high for this approximation.  Windows of -1 to +2 months were 
permitted for the follow-up visits; in sensitivity analyses these were restricted to -0.5 to +1 months.  
Cost-effectiveness analyses were performed from the health system and societal perspectives. Cost 
estimates were computed for a) the 6-month period of service use covering the third trimester and 
the first 3 months post-childbirth; b) the 3-month period of service use since the 3-month post-
childbirth assessment; and c) the total 9-month period of the trial covering the third trimester and the 
first 6 months post-childbirth.   
We used Ordinary Least Squares regression models, with margins to generate predicted mean costs. 
All analyses adjusted for the same baseline covariates as the effectiveness analyses. Incremental cost-
effectiveness ratios (ICERs) were derived for primary study outcomes using a non-parametric Monte-
Carlo bootstrapping technique (with 1000 replications), by random resampling of effectiveness 
outcomes and costs for THPP plus EUC and EUC-alone groups. Statistical analyses were conducted 
using Excel 2016 and Stata 14 for the cost-effectiveness analyses, and all other analyses were 
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conducted in Stata 14. The Data Safety and Monitoring Board independent of the NIMH oversaw the 
study. The trial is registered with ClinicalTrials.gov, registry number NCT02111915.  
Data sharing 
Data from our trial has been made available at the LSHTM data repository available at 
http://datacompass.lshtm.ac.uk/ (doi:10.17037/DATA.00000793). 
Role of the funding source 
The funder of the study had no role in study design, data collection, data analysis, data interpretation, 
or writing of the report, except for LP who was a Scientific Collaborator, under the cooperative 
agreement that funded the research. SS, IA, AZ, FV, HAW and AR had full access to trial data. SS and 
AR had final responsibility for the decision to submit for publication.  
 
RESULTS  
Between 15th October 2014 and 25th February 2016, 1910 pregnant women from the 40 village-
clusters were identified and approached (Figure 1). Of these, 154 (8%) were not eligible and 25 (1%) 
refused, leaving 1731 (91%) women who were screened using the PHQ-9 questionnaire. Of these 
women, 1159 (67%) were ineligible and 2 (<1%) refused, leaving 570 (33%) enrolled into the trial, 283 
in THPP plus EUC and 287 in EUC-alone groups. The proportions ineligible and refused were similar 
across the two groups. 
 
The mean age of participants was 27 years, all were married, >90% were not working outside the 
home, most did not have schooling beyond secondary, and the median baseline PHQ-9 score was 14 
(Table 1). There were no major imbalances between the groups, except a slightly higher proportion of 
women with chronicity of depression ≥12 weeks in the THPP plus EUC versus EUC-alone group 
(therefore this variable was adjusted for in the outcome analyses). 
At 6 months, 227 (80%) and 226 (79%) participants in the THPP plus EUC and EUC-alone groups, 
respectively, contributed primary outcome data (p=0·70). There was no evidence of a difference in 
baseline characteristics by availability of 6-month outcome data, except slightly longer time between 
screening and childbirth for those who do not have primary outcome data (therefore this variable was 
adjusted for in the outcome analyses; Appendix A); nor by having the visit in the protocol-defined 
window (Appendix B).  
There was some evidence of a beneficial intervention effect on symptom severity at 6 months post-
childbirth, with lower PHQ-9 scores in the THPP plus EUC group compared to EUC-alone (SMD=-0·13, 
95%CI -0·31 to 0·06, p=0·07, intra-cluster correlation coefficient (ICC) <0·001) (Table 2 and appendix 
C). There was little evidence of a difference between the groups with respect to the prevalence of 
remission at 6 months post-childbirth (PR=1·12, 95%CI 0·95, to 1·29, p=0·14, ICC <0·001) (Figure 2). 
Similarly, there was little evidence of effect modification for either symptom severity or remission 
(appendices D and E). Primary outcome results were robust to sensitivity analyses restricting the 
analysis window (appendix F), alternative model specifications and imputation of missing outcome 
data (appendices G and H). 
Figure 2 and Table 2 show the intervention effect, on depression, over the 6 months post-childbirth 
acorss groups; namely remission and recovery. While other secondary outcomes like disability, 
support and child outcomes are also shown.  
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Participants in the THPP plus EUC group were more likely than those in the EUC-alone group to have 
remission at 3 months (PR=1·18, 95%CI 1·06 to 1·29, p=0·002) and recovery (PR=1·36, 95%CI 1·09 to 
1·63, p=0.002)).  
Similarly, there was strong evidence that PHQ-9 score at 3 months was lower in the THPP plus EUC 
versus EUC-alone group (SMD=-0·30, 95%CI -0·48 to -0·11, p<0·001). Disability score (WHO-DAS) was 
also lower in the THPP plus EUC versus EUC-alone group at 3 months (SMD=-0·15 [-0·34 to 0·03], 
p<0·001), and to a lesser degree at 6 months (SMD=-0·11 [-0·29 to 0·08, p=0·23).  
In contrast, there was some evidence of an effect on social support (MSPSS score) at 3 months 
(SMD=0·10 [-0·08 to 0·29], p=0·12) compared to a larger effect at 6 months (SMD=0·20 [0·02 to 0·39], 
p=0·007).  
There was little evidence of an intervention effect on number of days unable to work in the last 
month at either 3 or 6 months (p=0·35 and p=0·71, respectively), exclusive breastfeeding (p=0·48 
and p=0·69, respectively), infant height for age (p=0·55 and 0·29, respectively) or infant weight for 
age (p=0·32 and p=0·50, respectively).  
 
In repeated measures analyses, there was little evidence of group by time interactions therefore we 
pooled the 3 and 6 month data assuming a constant intervention effect over time (Table 3). We 
found lower PHQ-9 score, higher prevalence of remission, lower disability score (WHO DAS), and 
higher social support (MSPSS score) in the THPP plus EUC group versus EUC-alone (p<0·001, p=0·02, 
p=0·03 and p=0·01, respectively). There was no evidence of a difference in number of days unable to 
work between the groups (p=0·47).  
Overall, 90 (16%) woman had at least one SAE, evenly distributed between the arms (p=0·72; appendix 
I). The most common SAEs were loss of child, hospitalisations (mainly of the child) and victimisation. 
There was no evidence of any differences between the groups.  
The Razakaars achieved 84% competency to deliver THPP sessions. The overall mean number of 
sessions attended by participants in the intervention group was 10·9 (standard deviation, SD 3·9, range 
0-14; out of 14). The mean number of sessions attended during the antenatal period was 3·7 (SD 1·7, 
range 0-5; out of 5) and during the postnatal period was 7·3 (SD 2·7, range 0-9; out of 9). 201/258 
(78%) participants completed treatment.  
Service use patterns and the costs of health care as well as foregone time and productivity are 
detailed in (Appendix J, K and L) for the THPP plus EUC and EUC-alone groups for the entire period of 
the trial (ie 3rd trimester of pregnancy to 6 months post-childbirth). The THPP intervention itself cost 
US$ 133 per beneficary to deliver. As summarised in Table 4, overall health system costs including 
the inervention were somewhat (but not statistically significantly) higher in the THPP plus EUC group 
at 3 and 6 months post-childbirth, but time and productivity losses were marginally lower. The 
adjusted mean difference in societal cost (health system and time costs combined) at 3 months post-
childbirth was US$ 6·56 (95%CI -44·01 to 57·13) and at 6 months post-childbirth was US$ 2·32 
(95%CI -18·04 to 22·68). The small additional societal cost associated with THPP is compensated for 
by a statistically significant improvement in PHQ-9 scores, resulting in incremental cost-effectiveness 
ratios of US$ 2·65 (95% CI 1·82 to 3·49) at 3 months post-childbirth, US$ 9·11 (95% CI -17·00 to 
35·22) for the period 3 to 6 months post-childbirth and US$ 15·50 (95% CI 9·59 to 21·61) for the 
period of the study as a whole. In summary, therefore, THPP offers an appreciable improvement in 
health at a low marginal cost. The probability of this finding is illustrated via the cost-effectiveness 
planes depicted in Figures 3& 4 illustrating 75% and 81% of the likelihood of THPP+EUC to be more 
effective but also more expensive than the EUC alone strategy under a health system and societal 
perspective, respectively. Over a willingness-to-pay threshold of US$ 60 per unit improvement on 
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PHQ-9, THPP+EUC was found to have an 98% probability of being a cost-effective choice compared 
to EUC alone (Appendix O) 
 
DISCUSSION 
To overcome the intractable barrier of human resource scarcity for mental health interventions in 
LMIC, we adapted the Thinking Healthy Programme for perinatal depression for delivery by volunteer 
peers in rural Pakistani settings. We took advantage of close-knit communities and the willingness of 
local women to take on the role of lay-therapists. Our results show that the intervention had a modest 
effect on reducing depressive symptoms and disability, and increasing the probability of remission of 
the depressive episode at 3 months post-childbirth; furthermore, the intervention delivery is low-cost 
and easily available that even this modest effect could have significant public health impact and that 
replications are essential. The effects waned by 6 months, possibly due to spontaneous remission of 
the depressive episode in control women; or them being an active control group. However, the 
moderate effects of the intervention on depression and disability at 3 months, a period when the 
mother is actively engaged in infant-care, remains an important finding that has several public health 
implications.  
To our knowledge, this is the first study (alongside the companion paper from India) where an 
evidence-based psychological intervention has been delivered successfully by lay women from the 
community with no formal health education or experience. Peers have been employed successfully in 
other areas of health29 but not for psychological interventions that are perceived to require a higher 
degree of skill-set and training. However, we were able to achieve this through careful adaptation of 
the psychological strategies, so that these became more intuitive and comprehensible to the peers. 
The peers received brief class-room training accompanied by field training and were able to deliver 
the intervention to satisfactory fidelity. A high proportion of women (78%) completed at least 10 
sessions out of the total possible 14, indicating the acceptability of the peers as delivery agents. Our 
feasibility studies showed that the depressed women and their family members engaged well with the 
peers and used these strategies to good effect.13 This has significant implications for initiatives to 
scale-up mental health in settings where there is a lack of formal workforce for this purpose. The peers 
worked in close partnership with the primary care system, forming a template for collaboration 
between the community and health services that can help address the treatment gap in a humane 
and feasible manner.  
The peers in the Pakistan site were volunteers and received no remuneration for their role. From the 
initial 66 peers, 45 were still retained in their role three years later; most of those who left did so due 
to changes in life-circumstances. Vacant positions were rapidly filled. Our formative work indicates 
that ‘altruistic’ peer role could be a form of social investment, a currency through which people pay 
each other. In other words, a peer in these rural settings might expect less direct financial return but 
may expect ‘in-kind’ returns from the community in case of need. This engagement of peers with the 
THPP may also be related to the availability of opportunity for women to progress their personal 
ambition outside of the family home. In rural Rawalpindi, such opportunities are limited, and therefore 
such a role may be a valuable stepping-stone towards greater respect from the community. A counter-
argument to the employment of volunteers is that it is a form of exploitation, and allows governments 
to shirk the responsibility of providing public health care which comes at a cost.30 Evidence shows that 
the type of remuneration is indeed context-specific and has implications for the acceptability and 
sustainability of the intervention, and its scaling up.31 
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The reduction in symptom severity, remission and disability was greatest within the first 3 months 
post childbirth – when the child care by mothers is at a critical stage. This may be explained by the 
intentional front-loading of the intervention, where 10 out of 14 sessions were delivered before 3 
months. Reducing the duration of morbidity and disability in a period of heightened vulnerability for 
both mother and infant is an important outcome. Notably the intervention also had a sustained effect 
as seen by repeated measures as well as by recovery and response across the six month post-childbirth 
period.  Recent evidence suggests that women with postpartum depression represent a heterogenous 
group of clinical subtypes32 who require varied interventions to help improve long-term treatment 
outcomes. Thus, our intervention can be conceputualized as the front-line, first step, intervention, in 
a stepped care system or a collaborative care model for maternal depression. 
We propose that mothers who show no response after the first three months of THPP should be 
offered a higher frequency of sessions during the final 3 months of treatment and/or should be 
stepped-up to a more intensive intervention delivered by a specialist provider.  
Further research is needed to explore if early response predicts long-term outcomes which might 
pave the way for more personalized allocation of treatment options which could start with provision 
of THPP to all women with perinatal depression, discontinuation of early responders after a few 
sessions, and more intensive interventions for non-responders after the first 3 months of treatment 
(with components added to address any other determinants of perinatal depression eg domestic 
violence). Such a programme would allow the recovery of as many mothers as possible through the 
stepped allocation of treatments of different intensities and would be tailored to individual need 
and response.  
The cost of delivering the intervention sessions was low, partly because the volunteers were not 
remunerated. This resulting in a very cost-effective strategy (an additional unit of improvement on 
the PHQ-9 symptom severity score costs between US$ 2-20 depending on the period of assessment 
and analytical perspective taken).  
A high proportion (45%) of participants in the EUC-alone group had remission at 6 months (albeit less 
than what we anticipated based on interim data from the companion India trial (Fuhr et al, companion 
paper), but higher than expected for the initial sample size calculations based on the original THP 
trial.8One possible explanation may be due to the phenomenon of regression toward mean. This is 
supported by a recent meta-analyses which shows that on average one-third of participants who 
receive no treatment for depression remit within 6 months post-childbirth.32 Natural remission seems 
to be greater for mild and moderate cases with depression.32-34 In addition it may be plausible that 
some non-specific elements in the control group may have mediated symptom improvement for EUC 
participants. Findings from our qualitative study indicate that participants have felt positive about 
outcome assessments as this provided an opportunity for participants to talk about their mood. This 
has been noted in other studies as well.35  
There are some limitations of our study. First, we did not employ diagnostic interviews to ascertain 
depression. Instead, we have used the PHQ-9, a validated screening tool which is simple to administer 
and has been used successfully in other studies in Pakistan. It has been validated in perinatal 
depression populations in Pakistan as mentioned above and other LMIC including in Ghana; PHQ-9 
shows acceptable criterion-related validity and reliability for screening for depressive symptoms 
among women in the antenatal and postnatal period. Second, generalizability of this peer-delivered 
psychological treatment, in the absence of existing community-based workers (eg Lady Health 
Workers) may be limited; since the peers worked in close collaboration with the LHWs. Similarly, the 
generalizability of findings to unmarried or non-pregnant women will be limited. Finally, a true 
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intention-to-treat analysis was not possible due to missing outcome data for about 20% of 
participants, but the results using complete case analysis adjusted for factors associated with 
missingness (primary analysis) and multiple imputation analysis (Appendices G and H) were similar. 
We found that the internal validity of the study was high; the trial conduct and analyses were robust; 
and there was a high participation rate, high adherence to the intervention with good fidelity of the 
intervention delivery, and low attrition. The companion paper from India has similar findings (Fuhr et 
al, companion paper), indicating that the study has good external validity. We found, across sites, that 
lay women as peers can feasibly be used for task-shifting mental health interventions in diverse 
settings and can be considered as the first stage of care in a collaborative care model for perinatal 
depression. In conclusion, the two studies open a promising avenue for further research if scaled-up 
versions are tried for bridging the treatment gap for common mental disorder in low-resource 
settings. 
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RESEARCH IN CONTEXT 
Evidence before this study  
Systematic reviews provide robust evidence that perinatal depression can be effectively managed 
with psychological treatments, and there is increasing global evidence that non-specialist health 
workers can effectively deliver such interventions in resource constrained settings.  
We conducted a systematic review to update earlier evidence on the topic to assess the effect of 
(non-pharmacological) psychological interventions on common perinatal mental disorders in LMIC. 
Seven electronic bibliographic databases including MEDLINE, EMBASE, CINAHL, PsycINFO, the 
British Nursing Index, the Allied and Complementary Medicine database and the Cochrane Central 
Register were searched from 1 January 2012 – 1 January 2018 combining search terms for 
depression and controlled evaluations. The search was restricted to English articles and studies 
conducted in LMIC. 17 trials on perinatal depression were retrieved. The pooled effect size was -
0.695, 95% CI= -0.92 to -0.47 for maternal depressive symptoms. The studies employed a range of 
delivery agents, including CHWs; however, none of the studies employed peers as delivery agents 
for the intervention. However, the largest reported effects have been achieved by the Thinking 
Healthy Program (THP), delivered by community healthcare workers to depressed mothers in rural 
Pakistan. The intervention based on cognitive behaviour therapy more than halved the rate of 
depression compared with usual care and led to significant improvements in women’s functioning 
and disability. However, efforts to integrate the intervention in the community healthcare workers’ 
daily routine at scale was compromised by their multiple health care responsibilities. Whether 
delivery of this intervention by lay persons such as peer volunteers is feasible or effective remains 
unclear. 
Added value of this study  
We adapted the Thinking Healthy Programme for delivery by peers working in close collaboration 
with the community healthcare workers. This study showed that the adapted intervention, which 
focused primarily on behavioural activation, was acceptable to participants and feasible to deliver 
by lay volunteer women in the community who had no previous health background. The 
intervention produced better outcomes than enhanced usual care and led to a moderate effect on 
symptom severity, remission from perinatal depression, disability severity and perceived social 
support at 3 months post-childbirth, with better recovery and response over 6 months postnatal. 
The intervention was also cost-effective.  
Implications of all the available evidence  
Psychological interventions such as THPP may be considered for scaling-up through peer workers 
as the first stage of care in a collaborative care model for perinatal depression.  
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Figures and Tables 
 
Figure 1: Trial profile  
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Table 1: Baseline characteristics  
 THPP plus EUC (n=283) EUC-alone (n=287) 
Age, years (mean [SD]) 26.80 [4·60] 27.28 [4·97] 
Marital status (n [%]) 
Married 
 
283 (100%) 
 
287 (100%) 
Occupation (of TP) (n [%]) 
Does not work 
Manual worker 
Non-manual worker 
 
263 (93%) 
18 (6%) 
2 (1%) 
 
270 (94%) 
13 (5%) 
4 (1%) 
Education status (of TP) (n [%]) 
None 
Primary 
Secondary 
Higher secondary 
Graduate/above 
 
52 (18%) 
68 (24%) 
120 (42%) 
25 (9%) 
18 (6%) 
 
55 (19%) 
71 (25%) 
113 (39%) 
21 (7%) 
27 (9%) 
Patient’s expectation of usefulness of 
counselling (n [%]) 
Not useful 
A little useful  
Somewhat useful 
Moderately useful 
Very useful 
Missing  
 
 
3 (1%) 
12 (4%) 
54 (19%) 
122 (43%) 
91 (32%) 
1 (<1%) 
 
 
1 (<1%) 
14 (5%) 
60 (21%) 
124 (43%) 
87 (30%) 
1 (<1%) 
Chronicity of depression, weeks 
(median [IQR]) 
Missing * 
 
23 (14-40) 
77 (27%) 
 
23 (15-34) 
94 (33%) 
PHQ-9 score [1] 
Median [IQR] 
 
14 [12-17] 
 
14 [12-17] 
PHQ-9 score category (n [%]) 
10-14 (moderate) 
15-19 (moderately severe) 
20-27 (severe) 
 
145 (51%) 
99 (35%) 
39 (14%) 
 
167 (58%) 
88 (31%) 
32 (11%) 
PHQ question 10 (n [%]) [2] 
Not difficult at all 
Somewhat difficult 
Very difficult 
Extremely difficult 
 
29 (10%) 
76 (27%) 
114 (40%) 
64 (23%) 
 
24 (8%) 
81 (28%) 
118 (41%) 
64 (22%) 
MSPSS score (mean [SD]) [1] 3.92 [1.41] 3.95 [1.33] 
Parity (n [%]) 
Primiparous  
Multiparous 
 
52 (18%) 
231 (82%) 
 
50 (17%) 
237 (83%) 
Previous miscarriages (n [%]) 
None (first pregnancy) 
None (not first pregnancy) 
One/more 
 
52 (18%) 
148 (52%) 
83 (29%) 
 
50 (17%) 
144 (50%) 
93 (32%) 
Previous still birth (n [%]) 
None (first pregnancy) 
None (not first pregnancy) 
One/more 
 
52 (18%) 
220 (78%) 
11 (4%) 
 
50 (17%) 
221 (77%) 
16 (6%) 
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 THPP plus EUC (n=283) EUC-alone (n=287) 
Any domestic violence in last 3 months 
(n [%]) 
No  
Yes  
Missing  
 
 
245 (87%) 
30 (11%) 
8 (3%) 
 
 
241 (84%) 
41 (14%) 
5 (2%) 
Time between screening and birth of 
child, months (mean [SD]) 
Missing [3] 
 
3·01 [1.27] 
39 (14%) 
 
2·97 [1.16] 
46 (16%) 
 [1] Question: If you checked off any problems (PHQ questions 1-9), how difficult have these problems made it for you to 
do your work, take care of things at home, or get along with other people? [2] Women who did not attend any follow up 
visits have missing information relating to the date of birth of the child. PHQ= Patient Health Questionnaire, 
MSPSS=Multidimensional Scale of Perceived Social Support. THPP= Thinking Healthy Programme Peer-delivered. 
EUC=enhanced usual care. SD=Standard Deviation. IQR=Interquartile range. * Chronicity was missed being asked in about 
1/3rd of our sample 
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Table 2: Primary and secondary outcomes  
 
THPP Plus EUC [1]  
 
Mean (SD) or n 
(%) 
 
EUC-alone [1] 
 
Mean (SD) or 
n (%) 
 
Standardised Mean 
Difference (SMD) or PR 
(95% CI) for THPP plus EUC 
vs EUC-alone [2] 
ICC [3] 
p-
value 
[2] 
Primary outcomes 
PHQ-9 score at 6 months 6·02 (5·92) 6·81 (6·22) SMD= -0·13 (-0·31 to 0·06) <0·001 0·07 
Remission (PHQ-9<5) at 6 
months 
112 (49%) 101 (45%) PR= 1·12 (0·95 to 1·29) 
 
<0·001 0·14 
Secondary outcomes  
PHQ-9 score at 3 months 
[4] 
6·11 (5.63) 7·82 (6·92) SMD= -0·30 (-0·48 to -
0·11) 
<0·001 
<0·001 
Remission (PHQ-9<5) at 3 
months [4] 
112 (50%) 93 (44%) PR= 1·18 (1·06 to 1·29) 
 
<0·001 0·001 
 
Recovery (PHQ-9<5 at 
both 3 and 6 months) [5] 
74 (35%) 51 (26%) PR= 1·36 (1·09 to 1·63) <0·001 0·002 
WHO-DAS Complex Score 
3 months [6]  15·48 (19.02) 17·50 (18·31) SMD= -0·15 (-0·34 to 0·03) <0·001 <0·001 
6 months  15·80 (19.83) 18·20 (21.83) SMD= -0·11 (-0·29 to 0·08) <0·001 0·23 
Number of days unable to 
work in past 30 days 
     
3 months [6] 1·28 (4.43) 1·55 (4·70) SMD= -0·07 (-0·26 to 0·12) <0·001- 0·35 
  6 months  1·07 (4·03) 0.97 (3·55) SMD= 0·02 (-0·17 to 0·20) <0·001 0·71 
MSPSS score  
3 months [4] 4·54 (1·18) 4·41 (1·25) SMD= 0·10 (-0·08 to 0·29) <0·001 0.12 
6 months  4·74 (1·33) 4·41 (1·37) SMD= 0·20 (0·02 to 0·39) <0·001 0·007 
Exclusive breastfeeding in last 24 hours 
3 months [4] 99 (44%) 98 (46%) PR= 0·94 (0·77 to 1·10) <0·001 0·48 
6 months  18 (8%) 19 (8%) PR= 0·89 (0·38 to 1·40) <0·001 0·69 
Height for age z score  
3 months [7] 0·20 (1·73) 0·05 (1.78) SMD= 0·05 (-0·14 to 0·24) <0·001 0·55 
6 months [6] 0·26 (1.70) 0·07 (1·92) SMD= 0·08 (-0·11 to 0·26) <0·001 0·29 
Weight for age z score 
3 months [8] -1·25 (1·25) -1·17 (1·22) SMD= -0·08 (-0·28 to 0·11) <0·001 0·32 
6 months [9] -0.90 (1·24) -0·85 (1·18) SMD= -0·06 (-0·24 to 0·13) <0·001 0·50 
[1] N=227 and 226 in the THPP plus EUC and EUC-alone groups, respectively, unless otherwise indicated. [2] Results from 
generalised estimating equation models, adjusted for union council, baseline PHQ-9 score, chronicity of depression, and time 
between screening and childbirth. [3] ICC reported only for primary outcomes. [4] N=223 and 211 in the THPP plus EUC 
and EUC-alone groups, respectively. [5] N=209 and 197 in the THPP plus EUC and EUC-alone groups, respectively. [6] 
N=223 and 210 in the THPP plus EUC and EUC-alone groups, respectively.  [7] N=217 and 207 in the THPP plus EUC and 
EUC-alone groups, respectively. [8] N=220 and 209 in the THPP plus EUC and EUC-alone groups, respectively. [9] N=226 
and 224 in the THPP plus EUC and EUC-alone groups, respectively. MSPSS=Multidimensional Scale of Perceived Social 
Support. THPP= Thinking Healthy Programme delivered by peers. EUC=enhanced usual care. PHQ-9=Patient Health 
Questionnaire 9. WHO-DAS=WHO -Disability Assessment Schedule. PR=Prevalence Ratio. ICC=Intra-cluster correlation. 
SD=Standard Deviation.  
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Table 3: Intervention effect for depression, disability and social support outcomes analysed as 
repeated measures   
 P value for 
group by 
time 
interaction 
Overall adjusted mean 
difference or OR (95% CI) 
for THPP plus EUC versus 
EUC-alone  
Overall adjusted 
Standardised Mean 
Difference or PR (95% CI) 
THPP plus EUC versus EUC-
alone  
P 
value 
for 
overall 
effect 
Primary outcomes     
PHQ-9 score  0·27 AMD=-1·37 (-2·01 to -0·74) SMD=-0·22 (-0·35 to -0·09) <0·001 
Remission (PHQ-9<5)  0·86 OR=1·32 (1·06 to 1·65) PR=1·15 (1·02 to 1·28) 0·02 
Secondary outcomes      
WHO DAS complex 
score 
0·89 AMD=-2·47 (-4·70 to -0·25) SMD=-0·12 (-0·25 to 0·01) 0·03 
Number of days unable 
to work 
0·58 AMD=-0·14 (-0·54 to 0·25) SMD=-0·03 (-0·17 to 0·10) 0·47 
MSPSS score 0·24 AMD=0·21 (0·05 to 0·37) SMD=0·16 (0·03 to 0·29) 0·01 
CI=Confidence Interval. PHQ-9=Patient Health Questionnaire (nine items). THPP=Thinking Healthy Program Peer-delivered, 
EUC=Enhanced Usual Care. MSPSS=Multidimensional Scale of Perceived Social Support. WHO-DAS=WHO Disability 
Assessment Scale. Results from generalised estimating equation models, adjusted for union council, baseline PHQ-9 score, 
chronicity of depression, time between screening and childbirth, and visit month.  
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Figure 2:  Intervention effect on remission and recovery by group over 6 months 
 
 
 
EUC=Enhanced Usual Care. THPP=Thinking Healthy Programme Peer-Delivered. Remission defined as PHQ-9 score <5; 
recovery defined as PHQ-9 score <5 at both 3 and 6 months. P-values are from GEE logistic regression models (to account 
for village clustering), adjusted for baseline PHQ-9 score, union council, time between screening and birth of the child and 
chronicity of depression (see methods for more details).  
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Table 4: Cost-effectiveness analysis from health system and societal perspectives at 3 & 6 months 
post childbirth and over the entire trial period. 
Notes: ICER, Incremental cost-effectiveness ratio 
Reference year 2015; services/costs included in the two totals (health system costs: in-patient/out-patient costs, costs of 
laboratory tests/investigations, medications, and intervention delivery (training and superivisng Razaakaars); societal costs: 
health system costs plus time/productivity costs)
 
1 Cost and outcome estimates relate to the 6-month period covering the third trimester and the first 3 months post-
childbirth 
2 Cost and outcome estimates relate to the 3-month period since the 3-month post-childbirth assessment 
3 Cost and outcome estimates relate to the 9-month period covering the third trimester and the first 6 months post-
childbirth  
4 Reduction in PHQ-9 scores converted to a positive change score to aid interpretation of cost-effectiveness results  
  Adjusted mean 
difference between 
THPP plus EUC and 
EUC-alone at  
3 months  
post-childbirth 1 
(Mean, 95% CI) 
 
Adjusted mean 
difference between 
THPP plus EUC and 
EUC-alone  
at  
6 months  
post-childbirth 2 
(Mean, 95% CI) 
Adjusted mean 
difference between 
THPP plus EUC and 
EUC-alone over total 
period of trial 3 
(Mean, 95% CI) 
 
COSTS       
a. Total Health system costs 
(incl. intervention) 
US$ 9·95 
[-35·29 to 55·20] 
US$ 4·08 
[-1·97 to 10·13] 
 
US$ 19·19 
[-22·98 to 61·37] 
 
b. Productivity costs US$ -3·39 
[-20·67 to 13·87] 
US$ -1·76 
[-18·45 to 14·91] 
US$ -1·71 
[-4·27 to 6·77] 
c. Total societal cost 
(Health System Cost+ 
Productivity Costs ) 
US$ 6·56 
[-44·02 to 57·13] 
US$ 2.32 
[-18·04 to 22·68] 
17.48 
[-33·28 to 68·25] 
OUTCOMES 
   
1. PHQ-9 summary score4 2·21 
[1·01 to 3·42] 
 
0·68 
[-0·67 to 2·03] 
1·51 
[0·28 to 2·73] 
 
2. Recovery difference between 
arms over total period of 
trial; number of cases (%)5  
23 (9%) 
  ICER  
(US$, 95% CI) 
ICER 
(US$, 95% CI) 
ICER 
(US$, 95% CI) 
COST-EFFECTIVENESS  
A. Total health system costs (incl. intervention) 
 Cost per unit change on PHQ-
9 summary score 
4·52  
(3·75 to 5·29) 
8·62 
(2·27 to 14·98) 
17·72 
(10·92 to 24·51) 
 Cost per case recovered 
(over total trial duration) 
  
236·12 
B. Total costs  
(health system and productivity costs) 
 Cost per unit change on PHQ-
9 summary score 
2·65 
 (1·82 to 3·49) 
9·11 
(-17 to 35·22) 
15·50 
 (9·39 to 21·61) 
 Cost per case recovered 
(over total trial duration) 
215·08 
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5 Recovery is defined as having less than 5 score on PHQ-9 at both 3 & 6 months post-childbirth time points 
Figure 3:  Cost-effectiveness plane 1: Health system perspective of THPP plus EUC compared to EUC-
alone per unit improvement in depression severity score over total period of trial 
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Figure 4: Cost-effectiveness plane 2: Societal perspective of THPP plus EUC compared to EUC-alone 
per unit improvement in depression severity score over total period of trial 
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